Sign In
Buy EVOK
$11.00
+0 (+0%)
At Close: Mar 16, 2026
Do Options Traders Know Something About Evoke Pharma (EVOK) Stock We Don't?
09:47am, Thursday, 17'th Dec 2020
Investors need to pay close attention to Evoke Pharma (EVOK) stock based on the movements in the options market lately.
Evoke Pharma Reports Third Quarter 2020 Financial Results
08:30am, Tuesday, 10'th Nov 2020
Gimoti™ commercial launch underway
Evoke and EVERSANA Announce Commercial Launch of Gimoti™
08:30am, Monday, 26'th Oct 2020
Product launch provides healthcare providers a novel treatment approach for patients suffering from symptoms of acute and recurrent diabetic gastroparesis Product launch provides healthcare providers
Evoke Pharma Reports Second Quarter 2020 Financial Results
12:30pm, Thursday, 06'th Aug 2020
Preparing for commercial launch of GIMOTI™ in 4Q 2020SOLANA BEACH, Calif., Aug. 06, 2020 (GLOBE NEWSWIRE) -- Evoke Pharma, Inc. (NASDAQ: EVOK), a specialty pharmaceutical company focused on treatmen
Evoke Pharma (EVOK) Receives a Rating Update from a Top Analyst - Markets
10:13am, Friday, 17'th Jul 2020
In a report released today, Ram Selvaraju from H.C. Wainwright reiterated a Buy rating on Evoke Pharma (EVOK – Research
Evoke Pharma Initiates Commercial Manufacturing of Gimoti™
12:30pm, Wednesday, 15'th Jul 2020
SOLANA BEACH, Calif., July 15, 2020 -- Evoke Pharma, Inc. (NASDAQ: EVOK), a specialty pharmaceutical company focused on treatments for gastrointestinal (GI) diseases, today.
Evoke Pharma Extends Cash Runway to 2Q 2021
12:30pm, Wednesday, 08'th Jul 2020
Based on its current operating plan, Evoke believes that its existing cash and cash equivalents will provide sufficient cash to fund its operations into the second quarter of 2021, without considerat
There's a Major Upside Catalyst Behind Evoke Pharma Stock
04:35pm, Monday, 29'th Jun 2020
Evoke Pharma received a nod of approval from the U.S. Food and Drug Administration, and investors can now have confidence in EVOK stock.
Evoke Pharma Set to Gain 170%? This 5-Star Analyst Thinks So
02:58am, Friday, 26'th Jun 2020
Gastrointestinal disease-focused Evoke Pharma (EVOK) kicked off the week in style. Monday, June 22, saw shares go through the roof, and by the end of the
The End Of A Record Green Streak, The Beginning Of Something New
12:00am, Friday, 26'th Jun 2020
After weeks of talking about it and anticipating what my total might look like at the end of it, I’ve finally managed to top the longest green streak of my career with the...
HC Wainwright Upgrades Evoke Pharma (NASDAQ:EVOK) to “Buy”
02:12am, Wednesday, 24'th Jun 2020
Evoke Pharma (NASDAQ:EVOK) was upgraded by equities research analysts at HC Wainwright from a “neutral” rating to a “buy” rating in a report released on Monday, Marketbeat.com reports. The bro
The Daily Biotech Pulse: Sanofi Expedites COVID-19 Vaccine Timeline, Apyx Cleared For Market Expansion, Miragen's Positive Readout
12:00am, Tuesday, 23'rd Jun 2020
The following is a roundup of top developments in the biotech space over the last 24 hours:
Scaling The Peaks
(Biotech Stocks Hitting 52-week Highs June 22)
ADC Therapeutics SA (...
Price Over Earnings Overview: Evoke Pharma
02:23pm, Monday, 22'nd Jun 2020
In the current session, Evoke Pharma Inc. (NASDAQ: EVOK) is trading at $4.15, after a 76.60% increase. Over the past month, the stock increased by 59.00%, and in the past year, by 639.22%. With perfor
Evoke Pharma Pops 86% In Pre-Market On FDA Approval Of Gimoti Nasal Spray
01:13pm, Monday, 22'nd Jun 2020
Evoke Pharma (EVOK) shares leaped 86% in pre-market trading after the U.S. Food and Drug Administration approved its Gimoti nasal spray for the treatment
U.S. stocks higher at close of trade; Dow Jones Industrial Average up 0.59%
12:00am, Monday, 22'nd Jun 2020
U.S. stocks higher at close of trade; Dow Jones Industrial Average up 0.59%
